ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting
Despite achieving recommended low-density lipoprotein cholesterol (LDL-C) targets, many patients remain at high risk of cardiovascular events due to elevated triglyceride-rich lipoproteins and remnants. Angiopoietin-like protein 3 (ANGPTL3) has emerged as a promising therapeutic target for addressin...
Sparad:
| Huvudupphov: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Frontiers Media S.A.
2026-01-01
|
| Serie: | Frontiers in Endocrinology |
| Ämnen: | |
| Länkar: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1706091/full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|